Advertisement
Screener

PROMETHEUS BIOSCIENCES, INC. Patents: Applications Pending

PROMETHEUS BIOSCIENCES, INC. Patent Applications Pending

8 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2019-07-12: Application 62873703; Invention GPR35 MODULATORS; Applicant Precision IBD, Inc.; Status Provisional Application Expired.
  • 2019-05-14: Application 62847798; Invention TL1A PATIENT SELECTION METHODS, SYSTEMS, AND DEVICES; Applicant Precision IBD, Inc.; Status Provisional Application Expired.
  • 2019-04-24: Application PCTUS2019028987; Invention OPTIMIZED ANTI-TL1A ANTIBODIES; Applicant PRECISION IBD, INC.; Status PCT - International Search Report Mailed to IB.
  • 2019-01-24: Application 62796459; Invention GPR35 MODULATORS; Applicant Precision IBD, Inc.; Status Provisional Application Expired.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2019-07-1262873703GPR35 MODULATORSPrecision IBD, Inc.Provisional Application Expired
Robert Higuchi
United States
2019-05-1462847798TL1A PATIENT SELECTION METHODS, SYSTEMS, AND DEVICESPrecision IBD, Inc.Provisional Application Expired
Laurens KRUIDENIER
Mahyar SABRIPOUR
United States
United States
2019-04-24PCTUS2019028987OPTIMIZED ANTI-TL1A ANTIBODIESPRECISION IBD, INC.PCT - International Search Report Mailed to IB
JEFFRY D. WATKINS
PATRICIA MCNEELEY
J. MONTY WATKINS
CINDY T. DICKERSON
United States
United States
United States
United States
YOUNG, LEE W
2019-01-2462796459GPR35 MODULATORSPrecision IBD, Inc.Provisional Application Expired
Robert Higuchi
United States
2018-12-2162784179METHODS AND SYSTEMS FOR SELECTION AND TREATMENT OF PATIENTS WITH INFLAMMATORY DISEASESPrecision IBD, Inc.
Cedars-Sinai Medical Center
Provisional Application Expired
Janine Bilsborough
Dermot P. McGovern
Stephan Targan
Alka Potdar
Jeffry D. Watkins
Cindy T. Dickerson
United States
United States
United States
United States
United States
United States
2018-11-0662756494OPTIMIZED ANTI-TL1A ANTIBODIESPrecision IBD, INC.Provisional Application Expired
Jeffry D. Watkins
Cindy T. Dickerson
J. Monty Watkins
United States
United States
United States
2018-06-0662681557METHODS AND SYSTEMS FOR SELECTION AND TREATMENT OF PATIENTS WITH INFLAMMATORY DISEASESPrecision IBD, Inc.
Cedars-Sinai Medical Center
Provisional Application Expired
Janine Bilsborough
Dermot P. McGovern
Stephan Targan
Alka Potdar
Jeffry D. Watkins
Cindy T. Dickerson
United States
United States
United States
United States
United States
United States
2018-04-2562662605OPTIMIZED ANTI-TL1A ANTIBODIESPrecision IBD, Inc.Provisional Application Expired
Jeffry D. Watkins
Cindy T. Dickerson
United States
United States